Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Selecta Biosciences (NQ: SELB )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Nov 13, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 0.8900 (5)
Ask (Size) 0.9000 (10)
Prev. Close 0.8812
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 115,079,292
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: WaveDancer, Inc. (Nasdaq – WAVD), Selecta Biosciences, Inc. (Nasdaq – SELB), Graphite Bio, Inc. (Nasdaq – GRPH), CapStar Financial Holdings, Inc. (Nasdaq – CSTR)
From Brodsky & Smith LLC
Via GlobeNewswire
Selecta Biosciences Merges Cartesian To Focus On Autoimmune Cell Therapy
Selecta Biosciences Inc (NASDAQ: SELB) and Cartesian Therapeutics Inc announced a reverse merger in an all-stock deal, with Selecta shareholders owning  
Via Benzinga

Performance

More News

Read More
Analyst Ratings for Selecta Biosciences
Via Benzinga
Selecta Biosciences Narrows R&D Focus On Gout Candidate
Via Benzinga
Recap: Selecta Biosciences Q1 Earnings
Via Benzinga
What 6 Analyst Ratings Have To Say About Selecta Biosciences
Via Benzinga
The Latest Analyst Ratings for Selecta Biosciences
Via Benzinga
Selecta Biosciences Earnings Perspective: Return On Capital Employed
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 18, 2023
Via Benzinga
Selecta, SOBI's Chronic Refractory Gout Program Meets Primary Goal, US Submission Expected Next Year
Via Benzinga
Why Cerberus Cyber Sentinel Shares Are Trading Higher By 147%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Earnings Preview For Selecta Biosciences
Via Benzinga
5 Value Stocks In The Healthcare Sector
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
The 7 Best Biotech Stocks to Buy for February 2023
Via InvestorPlace
Analyst Says Selecta Biosciences' Gout Candidate Can Potentially Raise The Bar On Several Fronts
Via Benzinga
Selecta Biosciences's Return On Capital Employed Insights
Via Benzinga
A Look Into Healthcare Sector Value Stocks
Via Benzinga
Selecta Biosciences: Q3 Earnings Insights
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Selecta Biosciences's Earnings Outlook
Via Benzinga
Why Rogers Shares Are Trading Sharply Lower; Here Are 33 Stocks Moving Premarket
Via Benzinga
Match Group, Super Micro Computer And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Via Benzinga
Earnings Scheduled For November 3, 2022
Via Benzinga
Selecta Biosciences's Return On Capital Employed Overview
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.